EL7.AI
StocksMedium•24 September 2026•
1 min read

APUS, SRZN, and GLND Stocks Surge on Strategic Deals and Regulatory Milestones

Key Facts

1Apimeds Pharmaceuticals shares surged about 115% on September 24, 2026, after its subsidiary MindWave Innovations signed a technology services agreement with AQUAE Holdings.
2Surrozen shares rose 108% in a rally linked to the Investigational New Drug application the company submitted to the FDA on September 8 for a diabetic macular edema treatment.
3Greenland Energy shares rose 83% after the extension of its Jameson Land agreement, and Greenland Mines shares rose about 33% after it raised more than $42 million.

Apimeds Pharmaceuticals shares surged about 115% on September 24, 2026, after its subsidiary signed a technology services agreement with AQUAE Holdings. Surrozen shares rose 108%, a rally Financial Modeling Prep linked to the Investigational New Drug application the company submitted to the FDA on September 8 for a diabetic macular edema treatment. Additionally, Greenland Energy shares rose 83% after the company extended its farm-out agreement with 80 Mile for the Jameson Land Basin, pushing the deadline for drilling its first exploration well to the end of 2028.

APUS closed at $4.92 on September 24, 2026, up from $2.29 in the previous session, while SRZN closed at $33.68, up from $16.16. In the energy and mining sectors, GLND closed at $5.35, up from $2.91, and GRML rose about 33% to $14.89 from $11.19 after Greenland Mines said it had raised more than $42 million in financing, as trading volume increased following material corporate catalysts in the small and mid-cap segments.